Modulation of the barrier function of the skin

被引:83
作者
Hadgraft, J [1 ]
机构
[1] Univ Greenwich, NRI, Chatham ME4 4TB, Kent, England
来源
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 2001年 / 14卷
关键词
skin penetration; physicochemical determinants; enhancers; retarders; stratum corneum; barrier function;
D O I
10.1159/000056393
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Transport of xenobiotics across the stratum corneum, the rate-control ling membrane of skin, is slow and the mechanism appears complex. However, the basic transfer is controlled by fundamental physicochemical concepts, the predominant of which are partition (K), diffusion (D) and solubility (C-s). In order to change the rate of penetration it is therefore clear that it is these parameters that should be targeted. In most instances enhancement strategies are adopted to improve D, K or C-s, however there are instances in which permeation reduction may be beneficial. Examples include the topical application of sunscreens or insect repellents. This publication demonstrates the way in which modulation effects can be assessed and the difficulties involved in determining which of the physicochemical parameter(s) are being affected. If the formulation influences more than one, synergism can often be seen. Advances in computer modelling have provided an insight into the mechanisms of action of some of the chemical enhancers at a molecular level. Enhanced skin absorption has been reported for the delivery of macromolecules such as insulin (associated with transfersomes) or DNA (as a DOTAP complex). The barrier property of the skin must be modulated for this to be achieved. However the precise mechanisms of action have not been elucidated. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:72 / 81
页数:10
相关论文
共 26 条
[1]   PERCUTANEOUS ABSORPTION - INVIVO EXPERIMENTS [J].
ALBERY, WJ ;
HADGRAFT, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1979, 31 (03) :140-147
[2]   LIPOSOME-MEDIATED GENE-TRANSFER AND EXPRESSION VIA THE SKIN [J].
ALEXANDER, MY ;
AKHURST, RJ .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2279-2285
[3]  
AMDIDOUCHE D, 1994, INT J PHARM, V111, P111
[4]   Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes [J].
Birchall, JC ;
Marichal, C ;
Campbell, L ;
Alwan, A ;
Hadgraft, J ;
Gumbleton, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 197 (1-2) :233-238
[5]   EXAMINATION OF THE EFFECT OF ETHANOL ON HUMAN STRATUM-CORNEUM INVIVO USING INFRARED-SPECTROSCOPY [J].
BOMMANNAN, D ;
POTTS, RO ;
GUY, RH .
JOURNAL OF CONTROLLED RELEASE, 1991, 16 (03) :299-304
[6]   The determination of a diffusional pathlength through the stratum corneum [J].
Bunge, AL ;
Guy, RH ;
Hadgraft, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 188 (01) :121-124
[7]   TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES [J].
CEVC, G ;
SCHATZLEIN, A ;
BLUME, G .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :3-16
[8]  
CROSS SE, IN PRESS PHARM RES
[9]  
DIAS MM, 2001, THESIS U WALES
[10]   AN ELECTRON-SPIN RESONANCE STUDY OF SKIN PENETRATION ENHANCERS [J].
GAY, CL ;
MURPHY, TM ;
HADGRAFT, J ;
KELLAWAY, IW ;
EVANS, JC ;
ROWLANDS, CC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (01) :39-45